Deutsche Bank reissued their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research report released on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a GBX 8,000 ($104.53) target price on the stock.
Other research analysts have also issued reports about the company. Liberum Capital reaffirmed a buy rating on shares of Reckitt Benckiser Group in a report on Thursday, July 11th. Barclays upped their price objective on Reckitt Benckiser Group from GBX 7,500 ($98.00) to GBX 8,100 ($105.84) and gave the company an overweight rating in a report on Tuesday, July 9th. UBS Group reaffirmed a neutral rating and issued a GBX 6,600 ($86.24) price objective on shares of Reckitt Benckiser Group in a report on Monday, July 29th. JPMorgan Chase & Co. reaffirmed an overweight rating on shares of Reckitt Benckiser Group in a report on Tuesday, July 16th. Finally, HSBC set a GBX 7,900 ($103.23) price objective on Reckitt Benckiser Group and gave the company a buy rating in a report on Thursday, July 18th. Four research analysts have rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of GBX 7,153.89 ($93.48).
Shares of LON RB opened at GBX 6,152 ($80.39) on Tuesday. The company has a current ratio of 0.65, a quick ratio of 0.47 and a debt-to-equity ratio of 80.49. The firm has a fifty day moving average price of GBX 6,430.86. Reckitt Benckiser Group has a one year low of GBX 5,559 ($72.64) and a one year high of GBX 7,174 ($93.74). The firm has a market cap of $43.62 billion and a price-to-earnings ratio of 20.18.
In other Reckitt Benckiser Group news, insider Christopher Sinclair acquired 1,076 shares of Reckitt Benckiser Group stock in a transaction that occurred on Thursday, May 23rd. The shares were acquired at an average cost of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52). Also, insider Adrian Nevil Hennah sold 13,701 shares of the firm’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
See Also: Stop Order
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.